Skip to main content

Find Clinical Trials

Home
Conditions
Neurofibromatosis 1

Clinical trial condition

Neurofibromatosis 1

Explore clinical trials studying Neurofibromatosis 1. Study availability and eligibility vary by location and protocol.

135 public trials 22 recruiting studies

Refine in advanced search Browse all conditions

Neurofibromatosis 1 trial results

Completed

Neurofibromatosis Type 1 Patient Registry

NCT01410006

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, Heredodegenerative Disorders, Nervous System, +14 more
Locations: Washington University St Louis, Missouri, United States

View Trial Details

Completed

Neurofibromatosis Type 1 Brain Tumor Genetic Risk

NCT01707836

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, Heredodegenerative Disorders, Nervous System, +15 more
Locations: Washington University St Louis, Missouri, United States

View Trial Details

Completed

Topical Imiquimod 5% Cream for Treatment of Cutaneous Neurofibromas in Adults With Neurofibromatosis 1

NCT00865644

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cutaneous Neurofibromas, Genetic Diseases, Inborn, +15 more
Locations: Massachusetts General Hospital Boston, Massachusetts, United States

View Trial Details

Completed

Trial to Evaluate the Safety of Lovastatin in Individuals With Neurofibromatosis Type I (NF1)

NCT00352599

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, Heredodegenerative Disorders, Nervous System, +13 more
Locations: Semel Institute for Neuroscience and Human Behavior Los Angeles, California, United States

View Trial Details

Completed

Ranibizumab for Neurofibromas Associated With Neurofibromatosis 1

NCT00657202

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cutaneous Neurofibromas, Genetic Diseases, Inborn, +17 more
Locations: Massachusetts General Hospital Boston, Massachusetts, United States

View Trial Details

Completed

Neuropsychological Impairment and Quality of Life in Neurofibromatosis Type 1

NCT01851135

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, Heredodegenerative Disorders, Nervous System, +14 more
Locations: Assistance Publique - Hôpitaux de Paris (Hôpital Henri Mondor) Créteil, France

Centre Hospitalier Universitaire de Nantes Nantes, France

View Trial Details

Completed

Resiliency Training for Patients With Neurofibromatosis Via Videoconferencing With Skype

NCT02298270

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cranial Nerve Diseases, Cranial Nerve Neoplasms, +30 more
Locations: Massachusetts General Hospital Boston, Massachusetts, United States

View Trial Details

Completed

Phase II Trial of Sunitinib (SU011248) in Patients With Recurrent or Inoperable Meningioma

NCT00589784

Conditions: Brain Diseases, Brain Neoplasms, CNS Cancer, +42 more
Locations: Dana Farber Cancer Institute Boston, Massachusetts, United States

Memoral Sloan Kettering Cancer Center Basking Ridge, New Jersey, United States

Memorial Sloan-Kettering Cancer Center at Commack Commack, New York, United States

Memorial Sloan-Kettering Cancer Center New York, United States

View Trial Details

Completed

Reliability of Functional Outcome Measures in Neurofibromatosis 1

NCT02479360

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, Heredodegenerative Disorders, Nervous System, +14 more
Locations: Neurofibromatosis Unit, Guys Hospital. London, United Kingdom

View Trial Details

Completed

Functional Imaging and Reading Deficit in Children With NF1

NCT02422732

Conditions: Communication Disorders, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dyslexia, +25 more
Locations: CHU Toulouse Toulouse, France

View Trial Details